These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18607693)

  • 21. [Biphasic insulin aspart (NovoMix 50)].
    Radermecker RP; Scheen AJ
    Rev Med Liege; 2008 Nov; 63(11):688-92. PubMed ID: 19112996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.
    Home PD; Barriocanal L; Lindholm A
    Eur J Clin Pharmacol; 1999 May; 55(3):199-203. PubMed ID: 10379635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections.
    Cemeroglu AP; Kleis L; Wood A; Parkes C; Wood MA; Davis AT
    Endocr Pract; 2013; 19(4):614-9. PubMed ID: 23425652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentration and Chemical Stability of Commercially Available Insulins: A High-Resolution Mass Spectrometry Study.
    Baechler F; Stettler C; Vogt B; Bally L; Groessl M
    Diabetes Technol Ther; 2020 Apr; 22(4):326-329. PubMed ID: 32031881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
    Home PD; Lindholm A; Hylleberg B; Round P
    Diabetes Care; 1998 Nov; 21(11):1904-9. PubMed ID: 9802741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin structure and stability.
    Brange J; Langkjoer L
    Pharm Biotechnol; 1993; 5():315-50. PubMed ID: 8019699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
    Lindholm A; McEwen J; Riis AP
    Diabetes Care; 1999 May; 22(5):801-5. PubMed ID: 10332685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
    Heinemann L; Weyer C; Rauhaus M; Heinrichs S; Heise T
    Diabetes Care; 1998 Nov; 21(11):1910-4. PubMed ID: 9802742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ammonia-treated N-(1-naphthyl) ethylenediamine dihydrochloride as a novel matrix for rapid quantitative and qualitative determination of serum free fatty acids by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Zhang Y; Wang Y; Guo S; Guo Y; Liu H; Li Z
    Anal Chim Acta; 2013 Sep; 794():82-9. PubMed ID: 23972979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical safety pharmacology studies on the rapid-acting insulin analogue insulin aspart.
    Dall V
    Arzneimittelforschung; 1999 May; 49(5):463-70. PubMed ID: 10367110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
    Hermansen K; Colombo M; Storgaard H; ØStergaard A; Kølendorf K; Madsbad S
    Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study.
    Thorisdottir RL; Parkner T; Chen JW; Ejskjaer N; Christiansen JS
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):216-21. PubMed ID: 19175369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
    Kildegaard J; Buckley ST; Nielsen RH; Povlsen GK; Seested T; Ribel U; Olsen HB; Ludvigsen S; Jeppesen CB; Refsgaard HHF; Bendtsen KM; Kristensen NR; Hostrup S; Sturis J
    Pharm Res; 2019 Feb; 36(3):49. PubMed ID: 30746556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
    da Silva DC; Lima LMTR
    Int J Pharm; 2018 Aug; 547(1-2):621-629. PubMed ID: 29928940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers.
    Kaku K; Matsuda M; Urae A; Irie S
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):119-26. PubMed ID: 10963823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus.
    Pettitt DJ; Ospina P; Kolaczynski JW; Jovanovic L
    Diabetes Care; 2003 Jan; 26(1):183-6. PubMed ID: 12502678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation.
    Russo I; Massucco P; Mattiello L; Cavalot F; Anfossi G; Trovati M
    Thromb Res; 2002 Jul; 107(1-2):31-7. PubMed ID: 12413586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics and pharmacodynamics of insulin aspart.
    Lindholm A; Jacobsen LV
    Clin Pharmacokinet; 2001; 40(9):641-59. PubMed ID: 11605714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.